Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products

Transfusion and Apheresis Science

Volumn 47, Issue 1, 2012, Pages 117-120

  Civriz Bozdag, S ^a   Bay, M ^a   Ayyildiz, E ^a   Topcuoglu, P ^a   Ilhan, O ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ADULT; AGE; AGED; APHERESIS; ARTICLE; CELL TRANSPLANTATION; CELL VIABILITY; CENTRIFUGATION; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD STEM CELL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; CELL SURVIVAL; CENTRIFUGATION; CRYOPRESERVATION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84862840157     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.05.012     Document Type: Article

References (19)

1. Zimmerman T.M., Mick R., Myers S., Bender J.G., Lee W.J., Williams S.F. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy. Bone Marrow Transplant 1995, 15(6):923-927.
2. Lee S., Kim S., Kim H., Baek E.J., Jin H., Kim J., et al. Post-thaw viable CD34(+) cell count is a valuable predictor of hematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Vox Sang 2008, 94(2):146-152.
3. Bakanay S.M., Dalva K., Arat M., Arslan O., Ayyi{dotless}ldi{dotless}z E., Beksac M., et al. Does continuous flow apheresis influence the viability in allogeneic hematopoietic stem cell harvest?. Transfus Apher Sci 2006, 34(2):171-178.
4. Hunt C. Cryopreservation of human stem cells for clinical application: a review. Transfus Med Hemother 2011, 38:107-123.
5. Berz D., Berz D., McCormack E., Winer E., Colvin G., Quesenberry P. Cryopreservation of hematopoietic stem cells. Am J Hematol 2007, 82(6):463-472.
6. Lovelock J.E., Bishop M.W. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 1959, 183:1394-1395.
7. Ferrucci P.F., Martinoni A., Cocorocchio E. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000, 25:173-177.
8. Zinno F., Landi F., Scerpa M.C., Aureli V., Lanti A., Ceccarelli S., et al. Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system. Transfusion 2011, 51(12):2656-2663.
9. Rowley S.D., Bensinger W.I., Gooley T.A., Buckner C.D. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994, 83:2731-2736.
10. Matsumoto N., Yoshizawa H., Kagamu H., et al. Successful liquid storage of peripheral blood stem cells at subzero non-freezing temperature. Bone Marrow Transplant 2002, 30:777-784.
11. Perez-Oteyza J., Bornstein R., Corral M., et al. Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Group for cryobiology and biology of bone marrow transplantation (CBTNO), Spain. Haematologica 1998, 83:1001-1005.
12. Pettengell R., Woll P.J., O'Connor D.A., Dexter T.M., Testa N.G. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time. Bone Marrow Transplant 1994, 14(5):703-709.
13. Balint B., Ivanovic Z., Petakov M., et al. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability. Bone Marrow Transplant 1999, 23:613-619.
14. Morris C., Siegel E., Barlogie B., et al. Mobilization of CD34+ cells in elderly patients with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003, 120:413-423.
15. Tempescul A., Ianotto J.C., Hardy E., Quivoron F., Petrov L., Berthou C. Peripheral blood stem cell collection in elderly patients. Ann Hematol 2010, 89:317-321.
16. Akkök C.A., Liseth K., Nesthus I., Løkeland T., Tefre K., Bruserud O., et al. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation. Transfusion 2008, 48:877-883.
17. Veeraputhiran M., Theus J., Pesek G., Barlogie B., Barlogie B., Cottler Fox M. Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration. Cytotherapy 2011, 13(10):1256-1258.
18. Vrhovac R., Perić Z., Jurenec S., Kardum-Skelin I., Jelić-Puskarić B., Jaksić B. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?. Coll Antropol 2010, 34(1):163-169.
19. Gratama J.W., Orfao A., Barnett D., Brando B., Huber A., Janossy G., et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. Cytometry 1998, 34(3):28-42.